The Russian Federation Expects That China will Produce More Than 150 Million Doses of Sputnik Per Year
"The Russian Direct Investment Fund plans that more than 150 million doses of vaccine per year will be produced by Chinese factories. Agreements have already been signed with six manufacturers. Test series of vaccines have been produced and approved by the quality control system of the Gamaleya Center at several sites, which already allows production to be scaled up." , - said in the message of the ministry following the results of the 8th meeting of the Intergovernmental Russian-Chinese Commission on Investment Cooperation.
The meeting was chaired by First Deputy Prime Minister Andrei Belousov and Deputy Prime Minister of the State Council of the People's Republic of China Han Zheng.
At the meeting, the parties agreed on a new list of significant projects of Russian-Chinese investment cooperation with a declared investment volume of over $ 120 billion. In particular, projects of Russian-Chinese international cooperation in the field of vaccine production - for $ 50 million, received the status of significant ones.
"Our Commission has become a platform for discussing cooperation between Russia and China in the fight against coronavirus, including the most important projects of the Russian Direct Investment Fund for organizing the production and commercialization of Russian Sputnik V and Sputnik Light vaccines," said Belousov, whose words are given in the message of the Ministry of Economic Development.
On November 26, the press service of the RDIF reported that its representatives took part in the 8th annual meeting of the Russian-Chinese intergovernmental commission on investment cooperation, where "joint efforts to combat the coronavirus pandemic were discussed, including the production and sale of Russian Sputnik V vaccines." and Sputnik Light in China and other markets. "